New Thieno-[2,3-d]pyrimidine-Based Functional Antagonist for the Receptor of Thyroid Stimulating Hormone

K. V. Derkach, A. A. Bakhtyukov, V. N. Sorokoumov, A.O. Shpakov

Research outputpeer-review

Abstract

Abstract: Thyroid stimulating hormone (TSH) receptor antagonists are required for the treatment of TSH-dependent tumors and Graves disease. We developed the compound 5-amino-N-(tert-butyl)-4-(4-iodophenyl)-2-(methylthio)thieno[2,3-d]pyrimidine-6-carboxamide (TP48) and showed that it reduces the TSH-stimulated adenylate cyclase activity in rat thyroid membranes. Pretreatment of rats with compound TP48 (ip, 40 mg/kg) reduced the increase in the levels of total and free thyroxin in blood and the increase in the expression of thyroglobulin and D2 deiodinase genes in the thyroid gland, which are responsible for the synthesis of thyroid hormones, which were caused by intranasal administration of thyroliberin to animals (300 μg/kg). These data indicate that compound TP48 is a functional antagonist of the TSH receptor and can be used to correct the thyroid status in hyperthyroidism.

Original languageEnglish
Pages (from-to)77-80
Number of pages4
JournalDoklady Biochemistry and Biophysics
Volume491
Issue number1
DOIs
Publication statusPublished - 1 Mar 2020

Scopus subject areas

  • Biophysics
  • Biochemistry
  • Chemistry(all)

Fingerprint Dive into the research topics of 'New Thieno-[2,3-d]pyrimidine-Based Functional Antagonist for the Receptor of Thyroid Stimulating Hormone'. Together they form a unique fingerprint.

Cite this